Bank of Montreal’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
EC
BI
DM
PM
SBH
FC
Bank of Montreal's LKFT Position: Q1 2024 in Review
Bank of Montreal sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 11,566 shares — an estimated $474K sold.
Bank of Montreal first reported a position in LKFT in Q3 2015 and held it in 25 quarters. The position peaked at $519K in Q1 2018. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.
- Bank of Montreal reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Bank of Montreal sold 11,566 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $474K.
- Bank of Montreal first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 25 quarters.
- Bank of Montreal's Lakefront Biotherapeutics American Depositary Shares position peaked at $519K in Q1 2018.
- 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.
Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.